0001123292-15-001273.txt : 20151030
0001123292-15-001273.hdr.sgml : 20151030
20151030180954
ACCESSION NUMBER: 0001123292-15-001273
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130918
FILED AS OF DATE: 20151030
DATE AS OF CHANGE: 20151030
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS INC
CENTRAL INDEX KEY: 0001175505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 260038620
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: TWO CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-365-5600
MAIL ADDRESS:
STREET 1: TWO CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hambleton Julie
CENTRAL INDEX KEY: 0001578771
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36070
FILM NUMBER: 151188802
MAIL ADDRESS:
STREET 1: C/O FIVE PRIME THERAPEUTICS, INC.
STREET 2: TWO CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2013-09-18
0001175505
FIVE PRIME THERAPEUTICS INC
FPRX
0001578771
Hambleton Julie
C/O FIVE PRIME THERAPEUTICS, INC.
TWO CORPORATE DRIVE
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
EVP & Chief Medical Officer
Common Stock
2013-09-18
4
P
0
800
14.75
A
800
I
By husband's IRA
Common Stock
2013-11-06
4
P
0
500
10.10
A
1300
I
By husband's IRA
Common Stock
2014-08-22
4
P
0
400
10.75
A
1700
I
By husband's IRA
Common Stock
2013-09-30
4
P
0
64
13.70
A
64
I
By son's custodial account
Common Stock
85919
D
Includes 179 shares granted to the reporting person by the Issuer pursuant to a company match under the Issuer's 401(k) plan.
/s/ Francis Sarena, Attorney-in-Fact
2015-10-30